On December 6, something extraordinary happened on Kossuth Square in front of the Hungarian Parliament. What began as a response to escalating police harassment of musicians, clubs, and young partygoers transformed into a vibrant, peaceful celebration of community, culture, and freedom: Dance for Freedom (Tánc a Szabadságért). [Updated with video!]

Clinical psychologist Brian Richards, Psy.D., explains how psychedelics can transform palliative care—from creating truly healing therapeutic spaces to supporting patients facing the end of life.

Scotland continues to face some of the highest drug-related death rates in Europe. The Scottish Drugs Forum Stop the Deaths conference in Glasgow brings together people who have lived this reality from every angle — families, frontline workers, people with lived and living experience, policymakers, and activists — to confront the scale of the emergency and demand meaningful change. Watch Drugreporter’s short documentary, filmed at this landmark event!

Two spiritual leaders from different faiths reveal how psychedelics are transforming their understanding of religion, community, and each other — watch Drugreporter’s new interview!

In Drugreporter’s new interview, trauma expert Bessel van der Kolk, MD explores how the body stores trauma and why integration is essential for healing in psychedelic therapy.

In Drugreporter’s new interview, German author Norman Ohler explores how psychedelics became entangled with war, power, and propaganda.

In Drugreporter’s new interview, Dominique Mendiola, Senior Director of Colorado’s Natural Medicine Division, shares how Colorado is shaping the next chapter of psychedelic regulation in the United States.

In Drugreporter’s new interview, Bill Richards, a pioneering psychologist and theologian who has explored the therapeutic and spiritual dimensions of psychedelics since the 1960s, reflects on the rebirth of psychedelic research and the enduring healing power of mystical experience.

In Drugreporter’s interview from Psychedelic Science 2025, Rick Doblin looks back on four decades of psychedelic activism and discusses the future after the FDA’s MDMA therapy rejection.

A harm reduction service that empowers young people to make healthy decisions and reduce the risks of drug use – watch Drugreporter’s new video on CheckIt!